Identification and Quantification of Anti-Gp.Mur Antibodies in Human Serum Using an Insect-Cell-Based System

Area of Science:

• Immunology
• Blood group serology
• Biotechnology

Background:

• The Gp.Mur antigen is prevalent in Asian populations and part of the MNS blood group system.
• Anti-Gp.Mur antibodies are linked to serious transfusion complications, including hemolytic transfusion reactions and hemolytic disease of the fetus and newborn.
• Current methods for detecting anti-Gp.Mur antibodies are inefficient and lack quantitative precision.

Purpose of the Study:

• To develop and validate a novel, quantitative cell-based system for the identification and quantification of anti-Gp.Mur antibodies.
• To improve diagnostic accuracy and efficiency in detecting clinically significant blood group antibodies.

Main Methods:

• Utilized a baculovirus expression system to display the Gp.Mur antigen on insect cell surfaces.
• Employed a quantitative cell-based hemagglutination inhibition assay using Gp.Mur-expressing insect cells and patient serum samples.
• Validated the system with known positive and negative serum samples, analyzing inhibition via densitometry.

Main Results:

• Insect cells expressing Gp.Mur antigen effectively adsorbed anti-Gp.Mur antibodies from patient sera.
• The cell-based system demonstrated inhibition of red blood cell agglutination mediated by anti-Gp.Mur antibodies.
• Quantitative analysis allowed for grading of agglutination levels and precise measurement of antibody inhibition.

Conclusions:

• The developed cell-based hemagglutination inhibition system offers a significant improvement over existing methods for anti-Gp.Mur antibody detection.
• This system provides a convenient and accurate means for both identifying and quantifying anti-Gp.Mur antibodies.
• The technology has potential to enhance transfusion safety and manage hemolytic disease of the fetus and newborn.